About Keith Greenfield
Form D filings for CyMon Bio in 2024 list Keith Greenfield as executive officer and director.
Keith Greenfield first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Keith Greenfield in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Keith Greenfield works with at each company, as listed on that company's latest Form D.
CyMon Bio, Inc. · Form D, Feb 12, 2024
TJ
Thomas Bliss, Jr.
President and director